• School of Ophthalmology & Optometry, Wenzhou Medical University, Wenzhou 325027, China;
Export PDF Favorites Scan Get Citation

X-linked retinoschisis (XLRS) is a rare X-linked inherited retinal disorder, caused by mutations in retinoschisin 1 (RS1) gene. Three XLRS mice were established, providing ideal systems to study the mechanism and treatment methods for XLRS. RS1 gene mutations can induce abnormal secretion or adhesion function of RS1 protein. In the past year, phase I clinical trials for XLRS has begun in USA, using adeno associated virus (AAV, AAV8 or AAV2)-mediated gene delivery. With the rapid development of new generation of AAV vector that can transduce more retinal cells through intravitreous delivery, gene therapy for XLRS will have a brighter future.

Citation: ZhangYangyang, DaiXufeng, ZhangHua, PangJijing. Molecular genetics and gene therapy of X-linked congenital retinoschisis. Chinese Journal of Ocular Fundus Diseases, 2016, 32(6): 657-660. doi: 10.3670/cma.j.issn.1005-1015.2016.06.027 Copy

  • Previous Article

    Clustered regularly interspersed short palindromic repeats/Cas9 gene editing and its research progress in ophthalmology
  • Next Article

    Zinc finger protein 408 in the pathogenesis of familial exudative vitreoretinopathy